Wanhai Xu

120 papers and 2.7k indexed citations i.

About

Wanhai Xu has authored 120 papers that have received a total of 2.7k indexed citations. This includes 58 papers in Molecular Biology, 28 papers in Pulmonary and Respiratory Medicine and 28 papers in Oncology. The topics of these papers are Nanoplatforms for cancer theranostics (24 papers), Bladder and Urothelial Cancer Treatments (17 papers) and Peptidase Inhibition and Analysis (14 papers). Wanhai Xu is often cited by papers focused on Nanoplatforms for cancer theranostics (24 papers), Bladder and Urothelial Cancer Treatments (17 papers) and Peptidase Inhibition and Analysis (14 papers) and collaborates with scholars based in China, United States and Russia. Wanhai Xu's co-authors include Da‐Yong Hou, Hao Wang, Man‐Di Wang, Xingjie Hu and Haojie Huang and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Advanced Materials

In The Last Decade

Rankless by CCL
2025